National Comparative Audit of Blood Transfusion

What is the National Comparative Audit?

The National Comparative Audit of Blood Transfusion (NCABT) is a programme of clinical audits which looks at the use and administration of blood and blood components in NHS and independent hospitals in England and North Wales.

For the last 14 years we have offered participation in our programme to hospitals served by the blood services in England, Northern Ireland, Scotland and Wales. The objective of the programme is to provide evidence that blood is being prescribed and used appropriately and administered safely, and to highlight where practice is deviating from the guidelines to the possible detriment of patient care.

The programme has been in operation since 2003 and is funded entirely by NHS Blood and Transplant through the blood pricing mechanism, and is one of the largest independently funded audit programmes in the UK. No charge is made to UK hospitals participating in it. 

Audits and surveys

For the 2018 Maternal anaemia audit go to the Pregnancy and childbirth page

2018 Audit of the management of major haemorrhage

2018 Survey of O D negative red cell use

2017 Audit of transfusion-associated circulatory overload

2017 Audit of red cell & platelet transfusions in haematology patients

2016 Audit of red cell transfusion in Hospices

2016 Audit of Patient Blood Management in adults undergoing elective, scheduled surgery

 

Schedule

Audits for 2020 have been postponed due to COVID-19:

  • Audit of Patient Blood Management in paediatric surgery 
  • Survey of use of FFP, cryoprecipitate, PCC and fibrinogen concentrate 
  • Audit of NICE Quality Standards
  • Audit of Blood Sample Collection & Labelling


Contact

John Grant-Casey
National Comparative Audit Programme Manager
Telephone: 07720 275388
john.grant-casey@nhsbt.nhs.uk